Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q1 2023 call → NOWe need to determine if the transcript describes a situation where the company is currently paying for something not yet earning, with a specific near-dated event that ends the wait, and management treats this as the main current work. Let's analyze the transcript. The company is Profire Energy, which makes burner management systems. They discuss strong results, revenue growth, etc. They mention supply chain disruptions, inventory buildup, and they are securing supplies for 2024. They also mention they are working with suppliers to obtain parts. They have a new product, the 2200 system, which is more challenging to get components for, and they are paying premiums to keep parts moving. They say the 2200 is the future, but they are selling more 2100s due to availability. They expect relief in 12-18 months. Is this a "waiting period" where they are paying for something not yet earning? They are paying higher prices for components for the 2200, but they are not yet selling many 2200s because of supply chain issues. They are investing in inventory and procurement. However, the company is still earning revenue from 2100s and other products. The cost is higher for 2200 components, but they are not yet selling many 2200s. So they are bearing extra cost for a product that is not yet generating significant revenue. The end of the wait is when supply chain improves, which they estimate in 12-18 months. They are already working on securing supplies for 2024. This seems like a situation where they are paying more now for future benefit. But is it a "defined waiting period" with a specific near-dated event? They say "relief coming in the next 12 to 18 months" - that's a bit vague. Also, they are not necessarily stopping other business; they are still profitable. The cost is not a huge drag; they have strong margins. The transcript does not emphasize that they are in a waiting period as their main work. They talk about growth, diversification, etc. The supply chain issues are a challenge, but they are managing. They don't say "we are paying for something that will start earning at a specific date." They say they are working to secure supplies for 2024, but that's just procurement. Also, they mention they have a new product, but they are not launching it; it's already launched but constrained by components. So the benefit has not fully arrived, but they are selling some.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.